Featured Articles

FDA's Delayed Announcement About Possible Insulin Overdoses Due To Recalled Syringes

Tom Lamb
November 07, 2008 12:36

Tyco Healthcare Group LP (Covidien) Recall Of ReliOn Disposable Syringes Was First Announced October 9, 2008; FDA Press Release About This Syringe Recall Is Dated November 5, 2008 (Posted by Tom Lamb at DrugInjuryWatch.com) By means of an October 9,...Tyco Healthcare Group LP (Covidien) Recall Of...

Recent Articles

950 NuvaRing Lawsuits Pending As Of December 31, 2011 According To Merck Annual Report

Tom Lamb
March 15, 2012 18:39

820 Cases Are Filed In Federal Court NuvaRing MDL And 125 Lawsuits Are Part Of New Jersey State Court Mass Tort (Posted by Tom Lamb at DrugInjuryWatch.com) The following information about the number of NuvaRing lawsuits that had been filed before January 2012 comes from page 119 of the Merck & Co.,...

Current First NuvaRing Trial Date: New Jersey State Court Bellwether Case Set For Early February 2013

Tom Lamb
March 15, 2012 18:10

Federal Court NuvaRing MDL Bellwether Trial Dates Pushed Back Several Times Previously; Perhaps It Will Be Late 2012 (Posted by Tom Lamb at DrugInjuryWatch.com) The first NuvaRing lawsuit has been scheduled to start trial in February 2013 pursuant to In Re: NuvaRing Litigation Case Management Order...

Fosamax Trial In New Jersey State Court Scheduled To Start Monday, February 27, 2012

Tom Lamb
March 14, 2012 17:11

The Flores Case And The Sessner Case Involve Incidents Of ONJ Jaw Injury, Not The Femur Fracture Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: During pretrial hearings Judge Higbee severed the Flores...

Fosamax - ONJ Litigation: Sessner v. Merck Trial In New Jersey State Court: Plaintiff's Opening Statement

Tom Lamb
March 14, 2012 17:10

Jury Is Told Numerous Times By Her Attorney That Fosamax Did Nothing For Sessner, It Only Did Something To Her (Posted by Tom Lamb at DrugInjuryWatch.com) During his March 5, 2012 opening statement the plaintiff's attorney, Tim O'Brien, told members of the jury numerous times that Fosamax did...

Yasmin / YAZ Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012

Tom Lamb
March 09, 2012 17:08

Bayer 2011 Annual Report: Settlement Agreements: 70 Cases Settled As of Mid-February 2012; Negotiations Will Continue On Case-by-Case Basis (Posted by Tom Lamb at DrugInjuryWatch.com) From February 1, 2011 to February 1, 2012 the number of lawsuits in the U.S. served upon Bayer involving side...

Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects

Tom Lamb
March 08, 2012 17:16

Prescriber Error, Impaired Renal Function, Patient Age, And Lack Of An Effective Reversal Agent Are Cited (Posted by Tom Lamb at DrugInjuryWatch.com) A Letter to The Editor, titled "Bleeding Risk with Dabigatran in the Frail Elderly" (subscription required), which appeared in the March 1, 2012...

Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills

Tom Lamb
February 29, 2012 16:47

Same General Warning About All COCs Was Added To YAZ In March 2011; And Why The One Year Delay, We Wonder (Posted by Tom Lamb at DrugInjuryWatch.com) The February 14, 2012 email captioned "What's New on the FDA Drugs Site" let us know that there was a new version of the Package Insert for Yasmin,...

Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings

Tom Lamb
February 14, 2012 13:22

At Increased Risk Are Patients Who Are Older, Have Altered Renal Clearance, Or Undergoing Atrial Fibrillation (AF) Ablation (Posted by Tom Lamb at DrugInjuryWatch.com) We first reported about Pradaxa (dabigatran) back in October 2011 in this article "New Heart Drug Pradaxa May Be Sending "Early"...

Gianvi Lawsuits Against The Drug Companies Still Possible After 2011 Supreme Court Preemption Ruling Re: Generic Drug Injury Lawsuits

Tom Lamb
February 09, 2012 16:08

Reason Is That Bayer Has Been Supplying Teva And Barr With The Product For Their Gianvi Pills Since December 2010 (Agreement Is Similar To Ocella Deal) (Posted by Tom Lamb at DrugInjuryWatch.com) Gianvi, a generic version of YAZ, is marketed by Teva Pharmaceuticals and Barr Laboratories, which are...